Reviva Pharmaceuticals Holdings Inc (RVPH)
1.36
-0.01
(-0.73%)
USD |
NASDAQ |
May 31, 16:00
1.37
+0.01
(+0.74%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Cash and Short Term Investments (Quarterly): 11.97M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.97M |
| December 31, 2023 | 23.37M |
| September 30, 2023 | 4.972M |
| June 30, 2023 | 11.15M |
| March 31, 2023 | 11.26M |
| December 31, 2022 | 18.52M |
| September 30, 2022 | 23.19M |
| June 30, 2022 | 19.42M |
| Date | Value |
|---|---|
| March 31, 2022 | 23.42M |
| December 31, 2021 | 29.69M |
| September 30, 2021 | 33.49M |
| June 30, 2021 | 35.80M |
| March 31, 2021 | 5.644M |
| December 31, 2020 | 8.760M |
| November 30, 2020 | 0.0366M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0366M
Minimum
Nov 2020
35.80M
Maximum
Jun 2021
17.38M
Average
18.52M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie Inc | 18.07B |
| ABVC BioPharma Inc | 0.1064M |
| Sutro Biopharma Inc | 313.22M |
| Flora Growth Corp | 4.156M |
| Journey Medical Corp | 24.06M |